Hepatoprotective Effect of Propagermanium onCorynebacterium parvumand Lipopolysaccharide‐Induced Liver Injury in Mice-Reference-Cited by-同舟云学术

Hepatoprotective Effect of Propagermanium onCorynebacterium parvumand Lipopolysaccharide‐Induced Liver Injury in Mice

Published:1998-08 Issue:2 Volume:48 Page:183-191
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scandinavian Journal of Immunology

Author:

Yokochi ¹,Ishiwata ¹,Hashimoto ¹,Ninomiya ¹,Suzuki ¹

Affiliation:

1. Developmental Research Department, Sanwa Kagaku Kenkyusho Co., Ltd, Mie, Japan

Publisher

Wiley

Subject

Immunology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-3083.1998.00356.x

Reference45 articles.

1. 1 C Hirayama, K Fujisawa, and H Suzuki Multicenter randomized controlled clinical trial of proxigermanium in chronic active hepatitis. VIIth Biennial Scientific Meeting of the Asian Pacific Association for the Study of the Liver. Jakarta, Indonesia: Asian Pacific Association for the Study of the Liver 1990 :102 .

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease;Communications Biology;2024-08-21

2. Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents;Cancer Science;2019-06-10

3. The Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease;International Journal of Molecular Sciences;2014-03-18

4. Hepatoprotective effect of germanium-containing Spirulina in rats with d-galactosamine- and lipopolysaccharide-induced hepatitis;British Journal of Nutrition;2013-06-17

5. Important role of CCR2 in a murine model of coronary vasculitis;BMC Immunology;2012-10-17